GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABL Bio Inc (XKRX:298380) » Definitions » Cash Flow for Lease Financing

ABL Bio (XKRX:298380) Cash Flow for Lease Financing : ₩-1,299 Mil (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is ABL Bio Cash Flow for Lease Financing?

ABL Bio's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ₩-323 Mil. ABL Bio's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-1,299 Mil.

Compared with last quarter (₩-322 Mil in Dec. 2023 ), ABL Bio's Cash Flow for Lease Financing remained the same in Mar. 2024 (₩-323 Mil).


ABL Bio Cash Flow for Lease Financing Historical Data

The historical data trend for ABL Bio's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABL Bio Cash Flow for Lease Financing Chart

ABL Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial -690.54 -885.99 -959.45 -1,091.47 -1,299.02

ABL Bio Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -322.88 -316.34 -337.73 -322.06 -322.70

ABL Bio Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-1,299 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ABL Bio Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of ABL Bio's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


ABL Bio (XKRX:298380) Business Description

Industry
Traded in Other Exchanges
N/A
Address
2nd Floor, 16 Daewangpangyo-Ro 712, Beon-Gil, Bundang-Gu, Gyeonggi-do, Seongnam-si, KOR, 13488
ABL Bio Inc is a Korean biotech research company. The company is engaged in the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline products include ABL001 an Bispecific Antibody, ABL201-205 an Antibody Drug Conjugate, T cell engager, Dual Immune Cell Targeting BsAb an Immuno-Oncology, ABL301 an BBB-Penetrating Bispecific Antibody.

ABL Bio (XKRX:298380) Headlines

No Headlines